Maglione et al. found increased serum levels of B-cell activating factor (BAFF) in CVID patients with a progressive course of ILD compared to stable GLILD, suggesting that a BAFF-mediated resistance to apoptosis drives pulmonary B cell hyperplasia within the lungs [6, 18]. Here, TNFSF13B is linked to common variable immunodeficiency.